Immune and inflammatory components

The term "Immune and inflammatory components" refers to a broad and diverse collection of biological entities, including cells, signaling proteins, and molecular pathways that coordinate the body's response to injury and infection. This category encompasses various elements such as cytokines, chemokines, toll-like receptors, and leukocyte subsets that facilitate both innate and adaptive immunity (Abbas et al., 2021). While these components are essential for maintaining homeostasis and defending against pathogens, their chronic or dysregulated activation is a primary driver of autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease (StatPearls, 2023). Because this is a descriptive grouping rather than a specific molecular entity, it does not serve as a single therapeutic target in drug development. Instead, pharmacological interventions are designed to modulate specific individual components within this system, such as TNF-alpha or JAK kinases, to achieve therapeutic effects (NIH, 2023). Consequently, this entry is classified as incorrect for the purposes of specific target identification due to its lack of molecular precision. It represents a physiological system or a set of pathways rather than a distinct protein, enzyme, or receptor that can be directly bound by a drug molecule.

Other names

Immune system componentsInflammatory mediatorsImmune-inflammatory pathways

Not applicable as this is a broad category of biological components rather than a single molecular target.